NeoGenomics to Report Third Quarter 2025 Financial Results

October 7, 2025 — Leads & Copy — NeoGenomics, Inc. (NASDAQ: NEO) will report its third quarter 2025 financial results before the U.S. financial markets open on Tuesday, October 28, 2025.

Company management will host a webcast and conference call at 8:30 a.m. ET to discuss financial results and recent highlights. The live webcast can be accessed at ir.neogenomics.com. It will be archived and available for replay shortly after the call’s conclusion.

To access the live call via telephone, dial (888) 506-0062 (domestic) or (973) 528-0011 (international) at least five minutes prior to the call. The participant access code is 392611.

NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services, offering a comprehensive oncology-focused testing menu. Headquartered in Fort Myers, FL, it operates a network of CAP-accredited and CLIA-certified laboratories throughout the US and in Cambridge, UK.

Source: NeoGenomics, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.